Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
kibero is a German life science imaging company that develops and sells very high frequency ultrasound and photoacoustic imaging systems for research, development, and quality control applications in the life sciences. The company was founded in 2007 as a spin-off from the Fraunhofer Institute for Biomedical Engineering and commercialized the SASAM technology under an exclusive license. Its product portfolio includes acoustic and photoacoustic microscopy systems such as SASAM, easySAM, easyPAM, AMI, and the clinical imaging system SKINSPECTION US/OA. kibero's systems are designed for non-destructive, high-resolution analysis of cells, tissues, spheroids, stem cells, blood, bone, and other biological specimens, with use cases spanning morphology, mechanics, and functional imaging. The company appears to operate primarily as an instrumentation and platform provider rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on kibero.